Pacific Edge Limited has published a shareholder letter outlining the company's current position regarding Medicare coverage policy. The letter notes that Pacific Edge anticipates a meeting with the Novitas expert panel, with an outcome expected to influence the development of a draft Local Coverage Determination (LCD) for Cxbladder tests. The letter states that an informal transcript of the meeting will be made available prior to the end of a trading halt, and the draft LCD is expected between the middle of the second quarter and early third quarter of calendar year 2026. The letter also addresses test volumes for the third quarter of 2026 and upcoming developments related to Medicare reimbursement. The full letter can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Edge Limited published the original content used to generate this news brief on January 19, 2026, and is solely responsible for the information contained therein.